Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Cavalieri

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|July 16, 2009
Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory actionSofia Mariotto, Alessandra Carcereri de Prati, Elisabetta Cavalieri, et al.
Free Radical Biology & Medicine|October 8, 2013
Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugsElena Butturini, Alessandra Carcereri de Prati, Giulia Chiavegato, et al.
Mechanisms of Ageing and Development|April 26, 2003
Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supplyEugenio Mocchegiani, Mario Muzzioli, Robertina Giacconi, et al.
Cell Death & Disease|November 27, 2019
BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomesAntonella Rigo, Isacco Ferrarini, Erika Lorenzetto, et al.
The FEBS Journal|July 3, 2009
Involvement of mitochondrial permeability transition pore opening in alpha-bisabolol induced apoptosisElisabetta Cavalieri, Christian Bergamini, Sofia Mariotto, et al.
Plos One|October 12, 2012
α-bisabolol is an effective proapoptotic agent against BCR-ABL(+) cells in synergism with Imatinib and NilotinibMassimiliano Bonifacio, Antonella Rigo, Emanuele Guardalben, et al.
Current Medicinal Chemistry|August 17, 2005
STAT1 as a new molecular target of anti-inflammatory treatmentAlessandra Carcereri de Prati, Anna Rosa Ciampa, Elisabetta Cavalieri, et al.
Nitric Oxide : Biology and Chemistry|March 3, 2005
Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO productionSofia Mariotto, Elisabetta Cavalieri, Ernesto Amelio, et al.
Experimental Gerontology|January 5, 2002
MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humansEugenio Mocchegiani, Robertina Giacconi, Catia Cipriano, et al.
Journal of Translational Medicine|April 23, 2011
Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cellsElisabetta Cavalieri, Antonella Rigo, Massimiliano Bonifacio, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|July 16, 2009
Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory actionSofia Mariotto, Alessandra Carcereri de Prati, Elisabetta Cavalieri, et al.
Free Radical Biology & Medicine|October 8, 2013
Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugsElena Butturini, Alessandra Carcereri de Prati, Giulia Chiavegato, et al.
Mechanisms of Ageing and Development|April 26, 2003
Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supplyEugenio Mocchegiani, Mario Muzzioli, Robertina Giacconi, et al.
Cell Death & Disease|November 27, 2019
BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomesAntonella Rigo, Isacco Ferrarini, Erika Lorenzetto, et al.
The FEBS Journal|July 3, 2009
Involvement of mitochondrial permeability transition pore opening in alpha-bisabolol induced apoptosisElisabetta Cavalieri, Christian Bergamini, Sofia Mariotto, et al.
Plos One|October 12, 2012
α-bisabolol is an effective proapoptotic agent against BCR-ABL(+) cells in synergism with Imatinib and NilotinibMassimiliano Bonifacio, Antonella Rigo, Emanuele Guardalben, et al.
Current Medicinal Chemistry|August 17, 2005
STAT1 as a new molecular target of anti-inflammatory treatmentAlessandra Carcereri de Prati, Anna Rosa Ciampa, Elisabetta Cavalieri, et al.
Nitric Oxide : Biology and Chemistry|March 3, 2005
Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO productionSofia Mariotto, Elisabetta Cavalieri, Ernesto Amelio, et al.
Experimental Gerontology|January 5, 2002
MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humansEugenio Mocchegiani, Robertina Giacconi, Catia Cipriano, et al.
Journal of Translational Medicine|April 23, 2011
Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cellsElisabetta Cavalieri, Antonella Rigo, Massimiliano Bonifacio, et al.
Pageof 2